Name: UMIN ID:
Unique ID issued by UMIN | UMIN000038918 |
---|---|
Receipt number | R000044364 |
Scientific Title | PHarmacological Audit study of Safety and Effectiveness in Real world (Phase R): Opioid for Cancer Dyspnea Study |
Date of disclosure of the study information | 2019/12/20 |
Last modified on | 2023/06/21 10:37:12 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/12/18 13:29:43 | ||
2 | Update | 2020/06/18 10:19:59 | Recruitment status |
|
3 | Update | 2020/12/17 19:38:25 | UMIN ID1 |
|
4 | Update | 2020/12/18 09:21:36 | Target sample size |
|
5 | Update | 2020/12/18 09:24:03 | Organization Organization Organization Category of Funding Organization |
|
6 | Update | 2021/06/19 13:40:57 | Last follow-up date Date of closure to data entry |
|
7 | Update | 2021/12/19 12:24:17 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2021/12/19 12:25:10 | Number of participants that the trial has enrolled |
|
9 | Update | 2021/12/19 12:33:16 | Organization Organization Division name Division name Zip code Address Address TEL Organization Organization Division name Division name Zip code Address Address TEL Institutions |
|
10 | Update | 2023/06/21 10:36:31 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
11 | Update | 2023/06/21 10:36:53 | Recruitment status |
|
12 | Update | 2023/06/21 10:37:12 | Publication of results |